PMDA announcement: FY2024 drug consultation intake report published
「2024年度くすり相談の受付状況」を掲載しました
Published: 2026-01-09 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Low · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The Pharmaceuticals and Medical Devices Agency (PMDA) announced on 2026-01-09 that it had published information on drug consultations received in fiscal year 2024. This is a publication announcement; the supplied title does not provide consultation figures or findings.
Business Impact
The report may be relevant to people seeking drug consultations, as it concerns consultation intake, but the title alone does not establish any operational implications for pharmaceutical businesses.
Recommended Action
Reviewing the official PMDA report may clarify the consultation figures, topics covered, and scope of the fiscal year 2024 reporting.